Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Reid Russell

Orthopaedic Surgery Hickory, NC Doctor of Osteopathy

NPI 1770965899 CMS profile 1352129

1771 Tate Blvd Se Ste 101, Hickory, NC 28602

Open in the dashboard

General payments

$17,349

131 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Reid Russell of Hickory, NC is reported in the CMS Open Payments database as having received $17,349 across 131 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $353 7
2024 General $1,488 18
2023 General $2,172 30
2022 General $292 8
2021 General $6,323 16
2020 General $2,935 5
2019 General $3,787 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Reid Russell
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Reid Russell were reported at $353. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Reid Russell Orthopaedic Surgery median Middle half National median
2019 $3,787 $644 $140–$2,844 $163
2020 $2,935 $312 $75–$1,860 $114
2021 $6,323 $520 $117–$2,495 $132
2022 $292 $598 $128–$2,731 $149
2023 $2,172 $461 $128–$2,264 $160
2024 $1,488 $497 $134–$2,475 $164
2025 $353 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $7,352 13 payments
  2. Stryker Corporation $1,876 29 payments
  3. Zimmer Biomet Holdings, Inc. $1,817 24 payments
  4. Arthrex, Inc. $1,675 22 payments
  5. Piedmont Plus Innovation $1,521 16 payments
  6. Supreme Orthopedic Systems, LLC $1,216 2 payments
  7. Medical Device Business Services, Inc. $1,011 9 payments
  8. Miach Orthopaedics, Inc. $225 1 payment
  9. Djo, LLC $148 1 payment
  10. DePuy Synthes Sales Inc. $121 2 payments
  11. Other $387 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $7,389 12 payments
  2. Travel and Lodging $6,271 29 payments
  3. Food and Beverage $3,689 90 payments
Products named General payments · program years 2019–2025
  1. VISIONAIRE $1,885 5 payments
  2. REGENETEN $1,497 2 payments
  3. FAST-FIX FLEX $1,051 4 payments
  4. Affixus $1,011 15 payments
  5. TRIATHLON $608 4 payments
  6. Comprehensive Fracture Shoulder $534 3 payments
  7. VARIAX $486 2 payments
  8. AXSOS $464 2 payments
  9. HOFFMANN $451 1 payment
  10. T2 $451 1 payment
  11. Other $3,096 60 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

224

Median for Orthopedic Surgery: 203

Drug cost

$1,746

Median for Orthopedic Surgery: $1,433

Branded share of claims

13.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 52 $941
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 31 $248
Tramadol Hcl Generic 35 $247
Meloxicam Generic 54 $110
Methylprednisolone Generic 19 $97
Oxycodone Hcl Generic 14 $61
Cyclobenzaprine Hcl Generic 19 $42

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$43,249

Of which drugs: $3,193

Medicare patients

116

Average age 73

Services billed

7,045

80 women, 36 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 32%
Ischemic heart disease 28%
Depression 26%
Chronic kidney disease 25%
Atrial fibrillation 23%
COPD 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 37 214 $153

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

131 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record